A Monoclonal Antibody Directed against aCandida albicansCell Wall Mannoprotein Exerts Three Anti-C. albicansActivities
- 1 September 2003
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 71 (9) , 5273-9
- https://doi.org/10.1128/iai.71.9.5273-5279.2003
Abstract
Antibodies are believed to play a role in the protection against Candida albicans infections by a number of mechanisms, including the inhibition of adhesion or germ tube formation, opsonization, neutralization of virulence-related enzymes, and direct candidacidal activity. Although some of these biological activities have been demonstrated individually in monoclonal antibodies (MAbs), it is not clear if all these anti-C. albicans activities can be displayed by a single antibody. In this report, we characterized a monoclonal antibody raised against the main target of salivary secretory immunoglobulin A in the cell wall of C. albicans, which exerts three anti-C. albicans activities: (i) inhibition of adherence to HEp-2 cells, (ii) inhibition of germination, and (iii) direct candidacidal activity. MAb C7 reacted with a proteinic epitope from a mannoprotein with a molecular mass of >200 kDa predominantly expressed on the C. albicans germ tube cell wall surface as well as with a number of antigens from Candida lusitaniae, Cryptococcus neoformans, Aspergillus fumigatus, and Scedosporium prolificans. MAb C7 caused a 31.1% inhibition in the adhesion of C. albicans to HEp-2 monolayers and a 55.3% inhibition in the adhesion of C. albicans to buccal epithelial cells, produced a 38.5% decrease in the filamentation of C. albicans, and exhibited a potent fungicidal effect against C. albicans, C. lusitaniae, Cryptococcus neoformans, A. fumigatus, and S. prolificans, showing reductions in fungal growth ranging from 34.2 to 88.7%. The fungicidal activity showed by MAb C7 seems to be related to that reported by antibodies mimicking the activity of a killer toxin produced by the yeast Pichia anomala, since one of these MAbs also reacted with the C. albicans mannoprotein with a molecular mass of >200 kDa. Results presented in this study support the concept of a family of microbicidal antibodies that could be useful in the treatment of a wide range of microbial infections when used alone or in combination with current antimicrobial agents.Keywords
This publication has 61 references indexed in Scilit:
- Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activityNature Biotechnology, 1997
- Reactivity of Candida albicans Germ Tubes with Salivary Secretory IgAJournal of Dental Research, 1996
- Effect of monoclonal antibodies directed against Candida albicans cell wall antigens on the adhesion of the fungus to polystyreneMicrobiology, 1996
- Variability in expression of antigens responsible for serotype specificity in Candida albicansMicrobiology, 1995
- Heat-Shock Mannoproteins as Targets of Secretory IgA in Candida albicansThe Journal of Infectious Diseases, 1994
- Distinct mechanisms of epithelial adhesion for Candida albicans and Candida tropicalis. Identification of the participating ligands and development of inhibitory peptides.Journal of Clinical Investigation, 1993
- Idiotypic Vaccination: Immunoprotection Mediated by Anti‐idiotypic Antibodies with Antibiotic ActivityScandinavian Journal of Immunology, 1993
- Stress proteins, infection, and immune surveillanceCell, 1989
- The diagnostic and therapeutic potential of a monoclonal antibody to the 60-kilodalton nuclear antigen of Candida albicansSerodiagnosis and Immunotherapy in Infectious Disease, 1989
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970